Fosun Pharma (02196.HK) has repurchased a total of 7.31 million A-shares and 2.365 million H-shares.

Capitalnews APP news. Fosun Pharmaceutical (02196.HK) announced that in April 2025, the company repurchased a total of 5,697,300 A-shares, accounting for approximately 0.2133% of the total share capital as of the close of April 30, 2025. The total repurchase amount is approximately RMB 135 million, with a highest price of RMB 24.03 per share and a lowest price of RMB 23.34 per share.